Benlysta Belimumab 400 mg Injection Single Use Vial 20 mL
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy \n
- BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy. \n
- BENLYSTA (belimumab) for injection is a sterile, preservative-free, lyophilized powder for reconstitution and dilution prior to intravenous infusion provided in single?dose glass vials with a rubber stopper (not made with natural rubber latex) and a flip?off seal. Each 20?mL vial contains 400 mg of belimumab. \n
- Requires Refrigeration
- Storage requirements:
- requires refrigeration
- Manufacturer #:
- 49401010201
- Brand:
- Benlysta
- Product dating:
- mckesson acceptable dating: we will ship >= 180 days
- Dosage form:
- injection
- Application:
- immunosuppressive agent
- UNSPSC:
- 51202403
- NDC number:
- 49401-102-01
- Manufacturer:
- Glaxosmithkline
- Type:
- intravenous
- Strength:
- 400 mg
- Mckesson #:
- 1184516
- Volume:
- 20 ml
- Container type:
- single use vial
- Generic drug name:
- belimumab
